Trials / Unknown
UnknownNCT04974190
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Lavandula Angustifolia Containing Nasal Spray Medical Device in Preventing Deterioration of COVID-19 in Symptomatic Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 550 (estimated)
- Sponsor
- The Grasses of Eden Ltd · Industry
- Sex
- All
- Age
- 16 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A Nasal Spray device containing Dead Sea minerals and plant extracts, used to shorten duration and mitigate effects of Covid-19 infection in mild to moderate adult patients
Detailed description
A Nasal Spray device containing Dead Sea minerals and plant extracts, designed to incur a PPAR-alpha agonistic effect, used to shorten duration and mitigate effects of Covid-19 infection in mild to moderate adult patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nasal Spray Device | A Nasal Spray apparatus containing a liquid |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2021-10-01
- Completion
- 2022-02-01
- First posted
- 2021-07-23
- Last updated
- 2021-07-23
Source: ClinicalTrials.gov record NCT04974190. Inclusion in this directory is not an endorsement.